The panel noted that a spot urine test is the standard tool with which to balance convenience and accuracy [13,91,92], and that UACR, instead of urine albumin concentration, should be measured, because it demonstrates a stronger association with future renal events in people with T2DM and nephropathy [93]. This evidence concerns the gene ALB and type 2 diabetes mellitus.